Há espaço para o tratamento endovascular nas dissecções crônicas da aorta descendente?

Dias, Ricardo Ribeiro; Judas, Gustavo Ieno; Oliveira, Marcos Danillo Peixoto; Malbouisson, Luíz Marcelo Sá; Fiorelli, Alfredo Inácio; Na, Stolf

doi:10.1590/s0102-76382007000400010

Cited by 3 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The false lumen would progressively dilate as a result of a patent re-entry site in the abdominal aorta, and the risk of rupture would persist. A study by Dias et al [ 14 ] in which endovascular treatment was used to treat 11 patients with chronic type B aortic dissections found that although stent-graft deployment was technically successful in all patients false lumen flows persisted in the thorax in 27% of the patients and in the abdomen in 82%, and that aortic diameter was not decreased postoperatively. The authors concluded that endovascular treatment of chronic type B dissections is not effective as it does not decrease aortic diameter.…”

Section: Discussionmentioning

confidence: 99%

Use of a stent-graft and vascular occlude to treat primary and re-entry tears in a patient with a Stanford type B aortic dissection

Shi¹,

Liu²,

Jiang³

2013

Revista Brasileira De Cirurgia Cardiovascular

View full text Add to dashboard Cite

Thoracic endovascular aortic repair for aortic dissections is recognized as an effective treatment. We herein report the case of a 72-year-old male with a Stanford type B aortic dissection. A stent-graft and double-disk vascular occluder was used to repair the primary and re-entry tears, respectively. At 3 month postoperatively, computed tomographic angiography revealed no endoleaks, the stent-graft and vascular occluder to be in optimal positions, the false lumen was almost completely thrombosed, and the visceral arteries were patent. This case illustrates that it is feasible to treat re-entry tears with a vascular occluder after primary proximal stent-graft repairs.

show abstract

Section: Discussionmentioning

confidence: 99%

Use of a stent-graft and vascular occlude to treat primary and re-entry tears in a patient with a Stanford type B aortic dissection

Shi¹,

Liu²,

Jiang³

2013

Revista Brasileira De Cirurgia Cardiovascular

View full text Add to dashboard Cite

show abstract

“…Lopera et al [ 27 ] , also reported that the presence of reentry at the level of the descending thoracic aorta associated with fibrosis in chronic cases, contribute to the reduced chance of sealing the intimal-middle layer and consequent reduction of thrombosis of the thoracic false lumen. Dias et al [ 28 ] , despite the small number of patients studied, concluded that the endovascular treatment of type B aortic dissection, in the chronic phase, did not decrease the diameter of the descending aorta and showed persistence of the false lumen in the descending segment of the thoracic aorta in 27.3% and abdominal aorta of 81.8%.…”

Section: Introductionmentioning

confidence: 99%

Indication of endovascular treatment of type B aortic dissection - Literature Review

Duarte¹,

Pontes²,

Benfatti³

et al. 2014

Revista Brasileira De Cirurgia Cardiovascular

View full text Add to dashboard Cite

Aortic dissection is a cardiovascular event of high mortality if not early diagnosed and properly treated. In Stanford type A aortic dissection, there is the involvement of the ascending aorta, whereas in type B the ascending aorta is not affected. The treatment of type A aortic dissection is mainly surgical. The hospital mortality of type B aortic dissection surgical treatment is approximately 20%, while medical therapy is 10%. However, half the patients who are discharged from hospital after medical treatment, progress to aortic complications in the following years, and the mortality in three to five years may reach 25-50%. In addition, the surgical treatment of aortic complications after medical treatment, has also a significant mortality. This way, the endovascular treatment comes up as an interesting alternative of a less invasive treatment for this disease. They presented a mortality rate lower than 10% with more than 80% success rate of occlusion and thrombosis of the false lumen. The INSTEAD TRIAL, which randomized patients with uncomplicated type B aortic dissection for optimal medical therapy and endovascular treatment in addition to optimal medical therapy, showed that after three years of follow up, patients who underwent endovascular treatment had lower mortality and aorta-related complications. Therefore, there is a current tendency to recommend the endovascular treatment as a standard for the treatment of type B aortic dissection

show abstract

“…Endovascular treatment of thoracic aortic diseases has progressed rapidly and led to a reduction in morbidity and mortality when compared to conventional surgery. The procedure is well established to treat descending thoracic and abdominal aorta pathologies [1][2][3][4][5]. However, only a few studies have reported on the treatment of lesions in the ascending aorta (AA) [6,7].…”

Section: Introductionmentioning

confidence: 99%

Correção endovascular da aorta ascendente associada a implante de stents coronários

Saadi¹,

Moura²,

Zago³

et al. 2011

Rev Bras Cir Cardiovasc

View full text Add to dashboard Cite

show abstract

Há espaço para o tratamento endovascular nas dissecções crônicas da aorta descendente?

Abstract: Despite the small number of studied patients, the endovascular procedure for chronic type B aortic dissections does not appear to be an option for the treatment of these patients.

Cited by 3 publications

References 23 publications

Use of a stent-graft and vascular occlude to treat primary and re-entry tears in a patient with a Stanford type B aortic dissection

Use of a stent-graft and vascular occlude to treat primary and re-entry tears in a patient with a Stanford type B aortic dissection

Indication of endovascular treatment of type B aortic dissection - Literature Review

Correção endovascular da aorta ascendente associada a implante de stents coronários

Contact Info

Product

Resources

About